Aptose Biosciences Stock Price, News & Analysis (TSE:APS)

C$3.38 +0.03 (+0.90 %)
(As of 02/19/2018 01:25 PM ET)
Previous CloseC$3.35
Today's RangeC$3.29 - C$3.46
52-Week RangeC$1.05 - C$4.80
Volume19,783 shs
Average Volume73,873 shs
Market CapitalizationC$95.84 million
P/E Ratio-4.12
Dividend YieldN/A
Beta2.97

About Aptose Biosciences (TSE:APS)

Aptose Biosciences Inc., a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology in Canada. Its lead clinical program is APTO-253, which is a Phase I clinical trial for the treatment of patients with relapsed or refractory hematologic malignancies. The company has an agreement with CrystalGenomics, Inc. to research, develop, and commercialize CG026806, a non-covalent small molecule therapeutic agent, which is in preclinical stage for the treatment of acute myeloid leukemia and chronic lymphocytic leukemia/mantle cell lymphoma. The company was formerly known as Lorus Therapeutics Inc. and changed its name to Aptose Biosciences Inc. in August 2014. Aptose Biosciences Inc. was founded in 1986 and is headquartered in Mississauga, Canada.

Receive APS News and Ratings via Email

Sign-up to receive the latest news and ratings for APS and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorN/A
SymbolTSE:APS
CUSIPN/A
Phone+1-647-4799828

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E Ratio-4.1219512195122
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

Trailing EPSC($0.82)
Net IncomeN/A
Net MarginsN/A
Return on Equity-103.60%
Return on Assets-92.86%

Miscellaneous

EmployeesN/A
Outstanding Shares27,050,000

Aptose Biosciences (TSE:APS) Frequently Asked Questions

What is Aptose Biosciences' stock symbol?

Aptose Biosciences trades on the Toronto Stock Exchange (TSX) under the ticker symbol "APS."

When will Aptose Biosciences make its next earnings announcement?

Aptose Biosciences is scheduled to release their next quarterly earnings announcement on Tuesday, March, 27th 2018. View Earnings Estimates for Aptose Biosciences.

Who are some of Aptose Biosciences' key competitors?

Who are Aptose Biosciences' key executives?

Aptose Biosciences' management team includes the folowing people:

  • William Glenn Rice, Chairman of the Board, President, Chief Executive Officer
  • Gregory Kwok Lee Chow, Chief Financial Officer, Senior Vice President
  • Denis R. Burger Ph.D., Independent Director (Age 70)
  • Erich M. Platzer M.D., Ph.D., Independent Director
  • Bradley Thompson, Independent Director
  • Mark D. Vincent M.D., Independent Director
  • Warren Whitehead, Independent Director

How do I buy Aptose Biosciences stock?

Shares of Aptose Biosciences and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.

What is Aptose Biosciences' stock price today?

One share of Aptose Biosciences stock can currently be purchased for approximately C$3.38.

How big of a company is Aptose Biosciences?

Aptose Biosciences has a market capitalization of C$95.84 million.

How can I contact Aptose Biosciences?

Aptose Biosciences' mailing address is 5955 Airport Rd Suite 228, MISSISSAUGA, ON L4V 1R9, Canada. The biotechnology company can be reached via phone at +1-647-4799828.


MarketBeat Community Rating for Aptose Biosciences (APS)

Community Ranking:  3.3 out of 5 (star star star)
Outperform Votes:  77 (Vote Outperform)
Underperform Votes:  41 (Vote Underperform)
Total Votes:  118
MarketBeat's community ratings are surveys of what our community members think about Aptose Biosciences and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Aptose Biosciences (TSE:APS) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.003.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: N/AN/AN/AC$16.00
Price Target Upside: N/AN/AN/A1,180.00% upside

Aptose Biosciences (TSE:APS) Consensus Price Target History

Price Target History for Aptose Biosciences (TSE:APS)

Aptose Biosciences (TSE:APS) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetDetails
10/23/2017Roth CapitalReiterated RatingBuyView Rating Details
9/7/2017HC WainwrightReiterated RatingBuyView Rating Details
11/16/2016Royal Bank of CanadaLower Price TargetOutperformC$16.00View Rating Details
(Data available from 2/19/2016 forward)

Earnings

Aptose Biosciences (TSE:APS) Earnings History and Estimates Chart

Earnings by Quarter for Aptose Biosciences (TSE:APS)

Aptose Biosciences (TSE APS) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/27/2018        
11/14/2017Q3 2017C($0.16)C($0.14)ViewN/AView Earnings Details
8/8/2017Q2 2017C($0.24)C($0.15)ViewN/AView Earnings Details
5/11/2017Q1 2017C($0.25)ViewN/AView Earnings Details
3/28/2017Q4 2016C($0.26)ViewN/AView Earnings Details
11/14/2016Q3 2016C($0.31)ViewN/AView Earnings Details
8/9/2016Q2 2016C($0.46)ViewN/AView Earnings Details
5/10/2016Q1 2016C($0.42)ViewN/AView Earnings Details
3/29/2016Q4 2015C($0.38)ViewN/AView Earnings Details
11/10/2015Q3 2015C($0.27)ViewN/AView Earnings Details
8/5/2015Q2 2015C($0.28)ViewN/AView Earnings Details
5/5/2015Q1 2015C($0.30)ViewN/AView Earnings Details
3/3/2015Q4 2014C($0.31)ViewN/AView Earnings Details
11/4/2014Q3 2014C($0.36)ViewN/AView Earnings Details
7/15/2014Q2 2014C($0.72)C($0.48)ViewN/AView Earnings Details
4/10/2014Q1 2014C($0.84)C($0.48)ViewN/AView Earnings Details
1/7/2014Q4 2013C($0.72)ViewN/AView Earnings Details
7/15/2013Q2 2013C($0.36)ViewN/AView Earnings Details
4/12/2013Q1 2013C($0.36)ViewN/AView Earnings Details
1/14/2013Q4 2012C($0.48)ViewN/AView Earnings Details
10/15/2012Q3 2012C($0.36)ViewN/AView Earnings Details
8/8/2012Q2 2012C$0.60ViewN/AView Earnings Details
4/12/2012Q1 2012C($0.58)ViewN/AView Earnings Details
1/13/2012Q4 2011C($0.83)ViewN/AView Earnings Details
11/11/2011Q3 2011C($0.77)ViewN/AView Earnings Details
8/26/2011Q2 2011C($0.72)ViewN/AView Earnings Details
4/12/2011Q1 2011C($1.21)ViewN/AView Earnings Details
1/14/2011Q4 2010C($1.33)ViewN/AView Earnings Details
10/15/2010Q3 2010C($1.40)ViewN/AView Earnings Details
8/30/2010Q2 2010C($2.16)ViewN/AView Earnings Details
4/14/2010Q1 2010C($0.05)ViewN/AView Earnings Details
1/14/2010Q4 2009C($0.12)ViewN/AView Earnings Details
10/6/2009Q3 2009C$0.44ViewN/AView Earnings Details
4/13/2009Q1 2009C$0.12ViewN/AView Earnings Details
1/14/2009Q4 2008C($0.11)ViewN/AView Earnings Details
10/9/2008Q3 2008C$0.12ViewN/AView Earnings Details
4/14/2008Q1 2008C$0.22ViewN/AView Earnings Details
1/8/2008Q4 2007C($0.16)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

Aptose Biosciences (TSE:APS) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Aptose Biosciences (TSE:APS)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Aptose Biosciences (TSE APS) Insider Trading and Institutional Ownership History

Insider Trades by Quarter for Aptose Biosciences (TSE:APS)

Aptose Biosciences (TSE APS) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/15/2017Warren WhiteheadDirectorBuy5,000C$1.95C$9,750.00
6/29/2017Warren WhiteheadDirectorBuy10,000C$1.64C$16,400.00
6/28/2017Gregory Kwok Lee ChowInsiderSell18,986C$1.20C$22,783.20
6/28/2017Warren WhiteheadDirectorBuy10,000C$1.60C$16,000.00
6/27/2017Warren WhiteheadDirectorBuy17,000C$1.51C$25,670.00
6/26/2017Gregory Kwok Lee ChowInsiderBuy10,000C$1.13C$11,300.00
6/26/2017William Glenn RiceDirectorBuy20,000C$1.14C$22,800.00
12/15/2015Warren WhiteheadDirectorBuy2,900C$3.38C$9,802.00
11/30/2015William Glenn RiceDirectorBuy4,000C$3.00C$12,000.00
11/24/2015Gregory Kwok Lee ChowInsiderBuy2,000C$3.44C$6,880.00
11/24/2015Mark VincentDirectorBuy1,000C$3.15C$3,150.00
5/11/2015William Glenn RiceDirectorBuy1,100C$5.94C$6,534.00
10/29/2014Sheldon InwentashInsiderBuy8,400C$8.52C$71,576.40
(Data available from 1/1/2013 forward)

Headlines

Aptose Biosciences (TSE APS) News Headlines

Source:
DateHeadline
Sprott, Aptose at 52-Week Highs - Baystreet.caSprott, Aptose at 52-Week Highs - Baystreet.ca
www.baystreet.ca - January 15 at 3:35 PM
OHSU and Aptose Present CG806 Preclinical Data at ASH 59th Annual Meeting - NasdaqOHSU and Aptose Present CG'806 Preclinical Data at ASH 59th Annual Meeting - Nasdaq
www.nasdaq.com - December 12 at 11:56 AM
OHSU and Aptose Present CG’806 Preclinical Data at ASH 59th Annual MeetingOHSU and Aptose Present CG’806 Preclinical Data at ASH 59th Annual Meeting
finance.yahoo.com - December 12 at 11:56 AM
Who Are The Largest Shareholders In Aptose Biosciences Inc (TSX:APS)?Who Are The Largest Shareholders In Aptose Biosciences Inc (TSX:APS)?
finance.yahoo.com - December 11 at 3:33 PM
Can Aptose Biosciences Inc (TSX:APS) Improve Your Portfolio Returns?Can Aptose Biosciences Inc (TSX:APS) Improve Your Portfolio Returns?
finance.yahoo.com - November 30 at 3:34 PM
Edited Transcript of APS.TO earnings conference call or presentation 14-Nov-17 10:00pm GMTEdited Transcript of APS.TO earnings conference call or presentation 14-Nov-17 10:00pm GMT
finance.yahoo.com - November 16 at 11:22 AM
Aptose Biosciences reports 3Q lossAptose Biosciences reports 3Q loss
finance.yahoo.com - November 16 at 11:22 AM
Aptose Biosciences Inc (APS) Scheduled to Post Earnings on TuesdayAptose Biosciences Inc (APS) Scheduled to Post Earnings on Tuesday
www.americanbankingnews.com - November 8 at 10:14 AM
Aptose To Release Third Quarter Ended September 30, 2017 Financial Results and Hold Conference Call on November 14, 2017Aptose To Release Third Quarter Ended September 30, 2017 Financial Results and Hold Conference Call on November 14, 2017
feeds.benzinga.com - November 7 at 8:26 AM
Aptose Biosciences (APTO) to Present New CG806 Data at ASH - StreetInsider.comAptose Biosciences (APTO) to Present New CG'806 Data at ASH - StreetInsider.com
www.streetinsider.com - November 1 at 4:32 PM
Why Aptose Biosciences Inc (TSX:APS) Could Be A BuyWhy Aptose Biosciences Inc (TSX:APS) Could Be A Buy
finance.yahoo.com - October 31 at 10:12 PM
Roth Capital Reiterates Buy Rating for Aptose Biosciences Inc (APS)Roth Capital Reiterates Buy Rating for Aptose Biosciences Inc (APS)
www.americanbankingnews.com - October 25 at 6:32 AM
Aptose Biosicences and CrystalGenomics Announce Issuance of U.S. Patent for CG’806Aptose Biosicences and CrystalGenomics Announce Issuance of U.S. Patent for CG’806
finance.yahoo.com - September 12 at 4:13 PM
HC Wainwright Reaffirms Buy Rating for Aptose Biosciences Inc (APS)HC Wainwright Reaffirms Buy Rating for Aptose Biosciences Inc (APS)
www.americanbankingnews.com - September 9 at 9:26 AM
Analyst Sees Near-Term Inflection Point For Aptose Biosciences, Upgrades StockAnalyst Sees Near-Term Inflection Point For Aptose Biosciences, Upgrades Stock
feeds.benzinga.com - September 7 at 9:47 AM
Aptose Reports Results for the Second Quarter Ended June 30, 2017 - GlobeNewswire (press release)Aptose Reports Results for the Second Quarter Ended June 30, 2017 - GlobeNewswire (press release)
globenewswire.com - August 8 at 8:49 PM
Aptose Biosciences Announces Results of Annual Meeting of Shareholders - NasdaqAptose Biosciences Announces Results of Annual Meeting of Shareholders - Nasdaq
www.nasdaq.com - June 6 at 8:41 PM
Aptose To Release First Quarter Ended March 31, 2017 Financial Results and Hold Conference Call on May 11, 2017 - GlobeNewswire (press release)Aptose To Release First Quarter Ended March 31, 2017 Financial Results and Hold Conference Call on May 11, 2017 - GlobeNewswire (press release)
globenewswire.com - April 26 at 9:10 AM
Aptose Announces Planned Departure of Chief Business Officer - NasdaqAptose Announces Planned Departure of Chief Business Officer - Nasdaq
www.nasdaq.com - March 27 at 8:12 AM
Aptose to Participate in Upcoming Investor Conferences - NasdaqAptose to Participate in Upcoming Investor Conferences - Nasdaq
www.nasdaq.com - March 2 at 3:50 PM
Q3 2016 Aptose Biosciences Inc Earnings Release - After Market CloseQ3 2016 Aptose Biosciences Inc Earnings Release - After Market Close
biz.yahoo.com - November 14 at 10:40 AM
Aptose Biosciences Inc Conference Call to Discuss on FDA Clinical Hold of APTO-253 scheduled for 8:30 am ET todayAptose Biosciences Inc Conference Call to Discuss on FDA Clinical Hold of APTO-253 scheduled for 8:30 am ET today
biz.yahoo.com - October 14 at 3:30 PM
15 Biggest Mid-Day Losers For Thursday15 Biggest Mid-Day Losers For Thursday
feeds.benzinga.com - October 13 at 2:11 PM
Q2 2016 Aptose Biosciences Inc Earnings Release - After Market CloseQ2 2016 Aptose Biosciences Inc Earnings Release - After Market Close
biz.yahoo.com - August 9 at 12:20 PM
Form 6-K Aptose Biosciences Inc. For: Jun 21Form 6-K Aptose Biosciences Inc. For: Jun 21
www.streetinsider.com - June 21 at 3:29 PM
Q1 2016 Aptose Biosciences Inc Earnings Release - After Market CloseQ1 2016 Aptose Biosciences Inc Earnings Release - After Market Close
biz.yahoo.com - May 10 at 7:07 AM
Aptose Biosciences Inc Earnings Call scheduled for 5:00 pm ET todayAptose Biosciences Inc Earnings Call scheduled for 5:00 pm ET today
biz.yahoo.com - November 10 at 5:00 PM
Q3 2015 Aptose Biosciences Inc Earnings Release - After Market CloseQ3 2015 Aptose Biosciences Inc Earnings Release - After Market Close
biz.yahoo.com - November 10 at 7:07 AM

SEC Filings

Aptose Biosciences (TSE:APS) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Financials are not available for this stock.

Chart

Aptose Biosciences (TSE APS) Stock Chart for Monday, February, 19, 2018

Loading chart…

This page was last updated on 2/19/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.